Literature DB >> 19038231

An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.

Eun Joo Noh1, Dae-Sik Lim, Gajin Jeong, Jong-Soo Lee.   

Abstract

Histone deacetylases (HDACs), a promising target for cancer therapy, play a role in regulating cell-cycle progression. The mechanisms for HDAC inhibition-induced regulation of G(2)/M transition and mitotic progression remain to be elucidated. Herein, we report that trichostatin A (TSA), an HDAC inhibitor, induces a delay at the G(2)/M transition, chromosome missegregation and multi-nucleation, and thereby leads to cell death by promoting exit from aberrant mitosis without spindle checkpoint. These results are associated with a transcriptional modulation of key regulator genes of the cell cycle, including CyclinB1, Plk1, Survivin, and p21(WAF1/Cip1). Actinomycin D, a transcriptional inhibitor, abrogated the TSA-induced delay of G(2)/M transition and transcriptional modulation of cell-cycle regulator genes, indicating that the impact of TSA in this manner is transcription dependent. Overall, our findings indicate that TSA provides a barrier to cell-cycle progression for antiproliferation and promotes escape from mitotic catastrophe and cell death, by inhibiting an HDAC-mediated transcriptional action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038231     DOI: 10.1016/j.bbrc.2008.11.057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.

Authors:  Jong-Shiaw Jin; Tang-Yi Tsao; Pei-Chang Sun; Cheng-Ping Yu; Ching Tzao
Journal:  Pathol Oncol Res       Date:  2012-01-20       Impact factor: 3.201

Review 2.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

Review 3.  Mitotic catastrophe: a mechanism for avoiding genomic instability.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04-29       Impact factor: 94.444

4.  The cytokine macrophage migration inhibitory factor (MIF) acts as a neurotrophin in the developing inner ear of the zebrafish, Danio rerio.

Authors:  Yu-chi Shen; Deborah L Thompson; Meng-Kiat Kuah; Kah-Loon Wong; Karen L Wu; Stephanie A Linn; Ethan M Jewett; Alexander Chong Shu-Chien; Kate F Barald
Journal:  Dev Biol       Date:  2011-12-22       Impact factor: 3.582

5.  Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma.

Authors:  Aaron P Havas; Kameron B Rodrigues; Anvi Bhakta; Joseph A Demirjian; Seongmin Hahn; Jack Tran; Margarethakay Scavello; Ana A Tula-Sanchez; Yi Zeng; Monika Schmelz; Catharine L Smith
Journal:  Cancer Biol Ther       Date:  2016-10-28       Impact factor: 4.742

6.  Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.

Authors:  Madeleine S Q Kortenhorst; Michel D Wissing; Ronald Rodríguez; Sushant K Kachhap; Judith J M Jans; Petra Van der Groep; Henk M W Verheul; Anuj Gupta; Paul O Aiyetan; Elsken van der Wall; Michael A Carducci; Paul J Van Diest; Luigi Marchionni
Journal:  Epigenetics       Date:  2013-07-19       Impact factor: 4.528

7.  Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells.

Authors:  Zhenya Hong; Zhiqiang Han; Min Xiao; Yang Yang; Xi Xia; Jianfeng Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

8.  Peptide arrays identify isoform-selective substrates for profiling endogenous lysine deacetylase activity.

Authors:  Zachary A Gurard-Levin; Kristopher A Kilian; Joohoon Kim; Katinka Bähr; Milan Mrksich
Journal:  ACS Chem Biol       Date:  2010-09-17       Impact factor: 5.100

9.  A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors.

Authors:  Jhanelle E Gray; Eric Haura; Alberto Chiappori; Tawee Tanvetyanon; Charles C Williams; Mary Pinder-Schenck; Julie A Kish; Jenny Kreahling; Richard Lush; Anthony Neuger; Leticia Tetteh; Angela Akar; Xiuhua Zhao; Michael J Schell; Gerold Bepler; Soner Altiok
Journal:  Clin Cancer Res       Date:  2014-01-15       Impact factor: 12.531

Review 10.  Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells.

Authors:  Anderly C Chueh; Janson W T Tse; Lars Tögel; John M Mariadason
Journal:  Antioxid Redox Signal       Date:  2014-03-27       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.